Medmix (MEDX.SW) traded up 1.35 % during a 24 hours period ending at 04:52 PM Central Europe on Monday 26th. One Medmix stock can currently be bought for about CHF 10.54 on popular exchanges. Current supply of Medmix stocks is 40.7 mn. Medmix has a current market capitalization of CHF 426.6 mn and approximately CHF 652.4 k worth of Medmix was traded on exchanges in the last 24 hours. Since last month end, Medmix has traded 6.61 % up. Simple moving average of last 200 days is at CHF 9.34. The highest price of past 52 weeks was recorded at CHF 12.36 on 01/26/2026. 52 weeks low was at CHF 7.61 on 07/23/2026.
Here is how related stocks have performed in the past 24 hours:
Komax (KOMN.SW) traded down -1.17 % and now trades at CHF 77.1. Current market capitalisation for Komax is CHF 388 mn.
Novavest Real Estate (NREN.SW) traded flat 0 % and now trades at CHF 37. Current market capitalisation for Novavest Real Estate is CHF 378.4 mn. Current price/earnings ratio for Novavest Real Estate is 11.54.
Metall Zug - B (METN.SW) traded flat 0 % and now trades at CHF 834. Current market capitalisation for Metall Zug - B is CHF 374.3 mn.
Schweiter (SWTQ.SW) traded down -1.44 % and now trades at CHF 349.5. Current market capitalisation for Schweiter is CHF 489.7 mn. Schweiter Technologies AG experienced a moderate rise in its share price during the day, contributing to the overall upward movement of the Swiss Market Index. The company’s stock advanced by roughly two percent, reaching a closing level above its previous day’s close. This gain helped lift the index to a new daily high, while the market remained broadly positive across the trading session. The company’s performance was noted alongside other gains in the index, although it was not among the strongest performers of the day. Overall, Schweiter Technologies’ movement reflected the general market trend and contributed to the index’s continued growth in the current trading period.
Vetropack (VETN.SW) traded down -0.11 % and now trades at CHF 18.1. Vetropack has a market capitalisation of CHF 364.8 mn. Veteropack Holding’s share performance has attracted attention after a detailed review of its A‑class stock revealed a significant decline over the past five years. The analysis highlighted that an investor who had allocated a modest sum into Vetropack A shares in 2021 would see the value of that investment fall markedly by late October 2026. While the stock was traded at a relatively high price in early 2021, the current trading level reflects a steep drop, indicating a notable contraction in market valuation. The report also clarified that the calculation did not take into account potential stock splits or dividend payments, which could slightly alter the overall outcome. Overall, the findings underscore the volatility experienced by the company’s equity and suggest that earlier investors have faced substantial losses relative to the original purchase price.
About Medmix
The MedMix AG is a Swiss company located in Zug that specializes in the design and production of high-precision delivery devices and applicators for various markets, including dental, drug delivery, surgery, industrial, and beauty. They offer self-injection and advanced biologic mixing devices, ready-to-use biologic, mixing and dispensing systems for adhesives and sealants, micro brushes, mascara, lip gloss, and concealers. You can find more information about their products and services on their website at www.medmix.swiss , and they are listed on the SIX Swiss Exchange.